---
title: "Cellectis posts presentation for June 25, 2026 AGM"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290880333.md"
description: "Cellectis released voting results from its June 25, 2026 AGM. Shareholders broadly backed the 2025 financial statements and renewed board mandates for four directors. The board was granted authority for share repurchases, capital reduction, bylaw amendments, and multiple capital-raising delegations, including US equity financing. A resolution to reserve capital increases for a savings plan passed despite significant opposition."
datetime: "2026-06-25T21:05:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290880333.md)
  - [en](https://longbridge.com/en/news/290880333.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290880333.md)
generator: "portal-rs"
---

# Cellectis posts presentation for June 25, 2026 AGM

-   Cellectis released voting results from its annual shareholder meeting. \* There was broad backing for the 2025 annual and consolidated financial statements and the allocation of results. \* Shareholders renewed board mandates for Jean-Pierre Garnier, Laurent Arthaud, Rainer Boehm, and Cécile Chartier. \* Investors granted the board authority to repurchase shares, cancel repurchased shares to reduce capital, and amend the chairman age limit in the bylaws. \* The meeting endorsed multiple delegations to raise capital through share or securities issuance, including with and without preferential subscription rights. \* These delegations included category-based placements and an at-the-market equity financing program in the US. \* A resolution to reserve a capital increase for a company savings plan drew heavy opposition (85.19% voting against), but it still carried. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cellectis SA published the original content used to generate this news brief on June 25, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [CLLS.US](https://longbridge.com/en/quote/CLLS.US.md)

## Related News & Research

- [MiniMed Group announces annual shareholder meeting](https://longbridge.com/en/news/296649574.md)
- [FS KKR Capital hosts shareholder meeting on share issuance proposal vote](https://longbridge.com/en/news/296534123.md)
- [Phancy Group announces extraordinary general meeting](https://longbridge.com/en/news/296507914.md)
- [Tempest Therapeutics special meeting adjourned after proposal fell short of required votes](https://longbridge.com/en/news/296266762.md)
- [Valion Bio amends 8-K to report final vote tally on reverse stock split approval](https://longbridge.com/en/news/296531983.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**